Minimal And Volatile RevenueThe company lacks commercial product revenues, which means its technology remains unproven in production. Without confirmed license deals or recurring sales, revenue visibility is near zero and long‑term viability depends on securing commercial partners and converting R&D into licensed products.
Structural Negative Cash FlowPersistent and growing cash burn implies continued external funding needs. Reliance on periodic financing increases dilution risk and constrains the pace of development and commercialization, making execution on licensing and integration timelines dependent on securing fresh capital.
Chronic Losses And Dilution RiskSustained operating deficits erode shareholder value and may force recurrent capital raises. Over time this can dilute existing holders, weaken incentives for long‑term investors, and pressure management to prioritize near‑term financing over disciplined commercial execution.